Intermittent use of sulphadoxine-pyrimethamine for malaria prevention: A cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Odongo, Charles O ^a,b   Bisaso, Ronald K ^a   Byamugisha, Josaphat ^a   Obua, Celestino ^a  

^a MAKERERE UNIVERSITY   (Uganda)

^b GULU UNIVERSITY   (Uganda)

Author keywords

IPTp; Malaria; Pregnant women; Sulphadoxine pyrimethamine; Uganda

Indexed keywords

PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT; DRUG COMBINATION; FANASIL, PYRIMETHAMINE DRUG COMBINATION; PYRIMETHAMINE; SULFADOXINE;

ADOLESCENT; ADULT; AGE; ARTICLE; ATTITUDE TO HEALTH; CLINICAL SUPERVISION; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DRUG SAFETY; EDUCATIONAL STATUS; FEMALE; HEALTH CARE ACCESS; HUMAN; MALARIA; MALARIA CONTROL; MEDICATION COMPLIANCE; OBSTETRICS; PARITY; PREGNANT WOMAN; PRENATAL CARE; PRIVATE HOSPITAL; UGANDAN; DRUG COMBINATION; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; STATISTICAL MODEL; UGANDA; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIMALARIALS; CROSS-SECTIONAL STUDIES; DRUG COMBINATIONS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALARIA; MEDICATION ADHERENCE; MODELS, STATISTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PYRIMETHAMINE; SULFADOXINE; UGANDA; YOUNG ADULT;

EID: 84925356069     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-399     Document Type: Article

References (42)

1. WHO: World Malaria Report 2012. Geneva, Switzerland: World Health Organization; 2013.
2. Uganda total fertility rate-demographics. Available from [www.indexmundi. com/uganda/total-fertility-rate.html]. Accessed December 9, 2013.
3. WHO: A Strategic Framework for Malaria Prevention and Control During Pregnancy in the African Region. Brazaville: HO Regional Office for Africa; 2004.
4. Chico RM, Chandramohan D: Intermittent preventive treatment of malaria in pregnancy: At the crossroads of public health policy. Trop Med Int Health 2011, 16:774-785.
5. Vallely A, Vallely L, Changalucha J, Greenwood B, Chandramohan D: Intermittent preventive treatment for malaria in pregnancy in Africa: whats new, whats needed? Malar J 2007, 6:16.
6. Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE: Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis 2011, 53:224-230.
7. O'Meara WP, Smith DL, McKenzie FE: Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. PLoS Med 2006, 3:e141.
8. White NJ: Intermittent presumptive treatment for malaria. PLoS Med 2005, 2:e3.
9. Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, MacArthur JR, Luntamo M, Ashorn P, Doumbo OK,Terkuile FO: Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-Analysis. JAMA 2013, 309:594-604.
10. Taylor SM, Antonia AL, Chaluluka E, Mwapasa V, Feng G, Molyneux ME, Kuile FO, Meshnick SR, Rogerson SJ: Antenatal receipt of sulfadoxinepyrimethamine does not exacerbate pregnancy-Associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study. Clin Infect Dis 2012, 55:42-50.
11. Kuile FO, van Eijk AM, Filler SJ: Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: A systematic review. JAMA 2007, 297:2603-2616.
12. Crawley J, Hill J, Yartey J, Robalo M, Serufilira A, Ba-Nguz A, Roman E, Palmer A, Asamoa K, Steketee R: From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy. Lancet Infect Dis 2007, 7:145-155.
13. Mbonye AK, Magnussen P, Bygbjerg IB: Intermittent preventive treatment of malaria in pregnancy: The effect of new delivery approaches on access and compliance rates in Uganda. Trop Med Int Health 2007, 12:519-531.
14. Msyamboza KP, Savage EJ, Kazembe PN, Gies S, Kalanda G, D'Alessandro U, Brabin BJ: Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi. Trop Med Int Health 2009, 14:183-189.
15. Akinleye SO, Falade CO, Ajayi IO: Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest. Nigeria: A cross-sectional study. BMC Pregnancy Childbirth 2009, 9:28.
16. Amoran OE, Ariba AA, Iyaniwura CA: Determinants of intermittent preventive treatment of malaria during pregnancy (IPTp) utilization in a rural town in Western Nigeria. Reprod Health 2012, 9:12.
17. Hill J, Kazembe P: Reaching the Abuja target for intermittent preventive treatment of malaria in pregnancy in African women: A review of progress and operational challenges. Trop Med Int Health 2006, 11:409-418.
18. Mubyazi GM, Bygbjerg IC, Magnussen P, Olsen O, Byskov J, Hansen KS, Bloch P: Prospects, achievements, challenges and opportunities for scaling-up malaria chemoprevention in pregnancy in Tanzania: The perspective of national level officers. Malar J 2008, 7:135.
19. Sangare LR, Stergachis A, Brentlinger PE, Richardson BA, Staedke SG, Kiwuwa MS, Weiss NS: Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja. Uganda. PLoS One 2010, 5:e15066.
20. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL: Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care 1996, 8:261-269.
21. Vermeire E, Hearnshaw H, Van Royen P, Denekens J: Patient adherence to treatment: Three decades of research. A comprehensive review. J Clin Pharm Ther 2001, 26:331-342.
22. Matsui D: Adherence with drug therapy in pregnancy. Obstet Gynecol Int 2012, 2012:796590.
23. Nordeng H, Ystrom E, Einarson A: Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol 2010, 66:207-214.
24. Mbonye AK, Neema S, Magnussen P: Perceptions on use of sulfadoxinepyrimethamine in pregnancy and the policy implications for malaria control in Uganda. Health Policy 2006, 77:279-289.
25. Mubyazi G, Bloch P, Kamugisha M, Kitua A, Ijumba J: Intermittent preventive treatment of malaria during pregnancy: A qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District. North-Eastern Tanzania. Malar J 2005, 4:31.
26. WHO Malaria Policy Advisory Committee and Global Malaria Programme: Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting. Malar J 2012, 11:424.
27. National Malaria Control Program: Uganda National Malaria Control Policy 2011. Kampala: Ministry of Health; 2011.
28. Cochran GW (Ed): Sampling Techniques. 2nd edition. New York: John Wiley and Sons, Inc.; 1963.
29. Ribera JM, Hausmann-Muela S, D'Alessandro U, Grietens KP: Malaria in pregnancy: what can the social sciences contribute? PLoS Med 2007, 4:e92.
30. Lauritsen JM: EpiData Entry, Data Management and basic Statistical Analysis System. Odense, Denmark: EpiData Association; 2006. URL http://www.epidata.dk.
31. R Core Team: R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2013. URL http://www.R-project.org/.
32. Sun GW, Shook TL, Kay GL: Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol 1996, 49:907-916.
33. Kiwuwa MS, Mufubenga P: Use of antenatal care, maternity services, intermittent presumptive treatment and insecticide treated bed nets by pregnant women in Luwero district, Uganda. Malar J 2008, 7:44.
34. Uganda Bureau of Statistics: Uganda Demographic and Health Survey 2011. Calverton, Maryland USA: ICF International Inc; 2012.
35. Kinney MV, Kerber KJ, Black RE, Cohen B, Nkumah F, Coovadia H, Nampala PM, Lawn JE, Science in Action: Saving the lives of Africas Mothers, Newborns, and Children working group, Axelson H, Bergh AM, Chopra M, Diab R, Friberg I, Odubanjo O, Walker N, Weissman E: Sub-Saharan Africas mothers, newborns and children: where and why do they die? PLoS Med 2010, 7:e1000294.
36. Pell C, Menaca A, Were F, Afrah NA, Chatio S, Taylor LM, Hamel MJ, Hodgson A, Tagbor H, Kalilandi L, Ouma P, Pool R: Factors affecting antenatal care attendance: results from qualitative studies in Ghana, Kanya and Malawi. PLoS One 2013, 8:e53747.
37. Simkhada B, Teijlingen ER, Porter M, Simkhada P: Factors affecting the utilization of antenatal care in developing countries: systematic review of the literature. J Adv Nurs 2008, 61:244-260.
38. Anders K, Marchant T, Chambo P, Mapunda P, Reyburn H: Timing of intermittent preventive treatment for malaria during pregnancy and implications for current policy on early uptake in north-east Tanzania. Malar J 2008, 7:79.
39. Kisuule I, Kaye DK, Najjuka F, Ssematimba SK, Arinda A, Nakitende G, Otim L: Timing and reasons for coming late for the first antenatal care visit by pregnant women at Mulago hospital, Kampala Uganda. BMC Pregnancy Childbirth 2013, 13:121.
40. Sangare LR, Weiss NS, Brentlinger PE, Richardson BA, Staedke SG, Kiwuwa MS, Stergachis A: Patterns of anti-malarial drug treatment among pregnant women in Uganda. Malar J 2011, 10:152.
41. Mbonye A, Birungi J, Yanow S, Magnussen P: Prescription patterns and drug use among pregnant women with febrile illnesses in Uganda: A survey in out-patient clinics. BMC Infect Dis 2013, 13:237-242.
42. Peters PJ, Thigpen MC, Parise ME, Newman RD: Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment. Drug Saf 2007, 30:481-501.